Home › Funds › Morgan Stanley › IMPLQ
Morgan Stanley position in IMPLQ
IMPEL PHARMACEUTICALS INC
Latest position (Q3 2023)2.00K sh
Reported value held$860
Portfolio Weight0.00%
First reportedQ3 2021
Last changeHold
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2021 | 6.35K | $78.00K | New |
| Q4 2021 | 12.08K | $105.00K | Add |
| Q1 2022 | 11.11K | $70.00K | Reduce |
| Q2 2022 | 15.67K | $145.00K | Add |
| Q3 2022 | 11.52K | $55.00K | Reduce |
| Q4 2022 | 2.14K | $8.03K | Reduce |
| Q1 2023 | 2.00K | $2.80K | Reduce |
| Q2 2023 | 2.00K | $2.54K | Hold |
| Q3 2023 | 2.00K | $860 | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding IMPLQ
No other tracked fund reports a position in IMPLQ.